Home / Stocks / DLCL
Back to all stocks
BSE · DLCL

DR LALCHANDANI LABS LIMITED

Sector: Healthcare · ISIN: INE871Z01013

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,802
of 5,088 stocks
▼ 1211W
Peak #4,681 · 21 Sep 2026

Operating in Healthcare, DR LALCHANDANI LABS LIMITED carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is seeing revenue slip. Ownership as of Mar 2026.

Market Cap
5.95 Cr
P/E Ratio
93.74
P/B Ratio
0.42
ROE
0.45%
ROCE
0.81%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

Quarterly financials for this stock haven't been ingested yet — check back soon.

Shareholding pattern

Promoter
32.90%
Public
67.10%

PUBLIC BREAKDOWN

Individuals
62.93%

As of 31 Mar 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
27 Jan 2026OtherRight Issue of Equity Shares

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs